NCT05151653View on ClinicalTrials.gov

A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

PHASE1CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions
Healthy
Interventions
DRUG

BI 765250

BI 765250

DRUG

Placebo

Placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05151653 - A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin | Biotech Hunter | Biotech Hunter